The CTSA funding to the Michigan Institute for Clinical and Health Research (MICHR) in 2007 marked the beginning of a transformation of clinical-translational research (CTR) at the University of Michigan (UM). This award, coupled with strong institutional support and growing faculty engagement, enabled UM to evolve from a predominantly basic science research institution to one with a comprehensive research portfolio. This has been achieved on the foundation of: integrated and innovative training and educational programs that have touched nearly 2,000 trainees, faculty and staff;centralization and optimization of previously fragmented research services to create innovative opportunities for users;$10.2M distributed for pilot studies to accelerate innovation;and researcher participation in new partnerships with our communities and across the CTSA National Consortium. In the renewal period, CTSA funding leveraged with robust institutional support will enable MICHR to pursue 5 Overarching Objectives: 1) Optimize training and mentoring to create the next generation of research teams and clinical and translational investigators;2) Augment infrastructure and refine research services to reduce barriers and maximize research productivity across the entire translational research continuum;3) Foster collaborations and leverage innovative approaches and technologies to catalyze discovery;4) Enhance community- and practice-based partnerships to assure bi-directional learning, research, and implementation of findings to benefit health;5) Actively lead and contribute to national CTSA Consortium activities and engage in cross-CTSA collaborations. These will be achieved by: expanding education into new areas to strengthen the pipeline of CTR investigators and deploying more flexible training tools;strengthening existing services and launching new ones to impact study start-up times and recruitment;employing major informatics investments to fully integrate the needs of CTR investigators into IT landscape;utilizing new practice-based research networks;expanding evaluation to efficiently assess and optimize our performance. MICHR will be the engine of improvement and innovation in the conduct of high-quality, high impact-clinical and translational research to advance the health of Michigan and the nation.
Translating scientific discoveries into real health gains is challenging. In recent decades this translation has been taking longer and costing more. The Michigan Institute for Clinical and Health Research provides infrastructure and services for researchers and increases access to research for the community. We help transform emerging knowledge into real changes in how we prevent and treat disease.
|Carlozzi, N E; Schilling, S; Kratz, A L et al. (2018) Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability? Qual Life Res :|
|Gurczynski, S J; Zhou, X; Flaherty, M et al. (2018) Bone marrow transplant-induced alterations in Notch signaling promote pathologic Th17 responses to ?-herpesvirus infection. Mucosal Immunol 11:881-893|
|Sperry, Zachariah J; Na, Kyounghwan; Parizi, Saman S et al. (2018) Flexible microelectrode array for interfacing with the surface of neural ganglia. J Neural Eng 15:036027|
|Rege, Juilee; Turcu, Adina F; Kasa-Vubu, Josephine Z et al. (2018) 11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche. J Clin Endocrinol Metab 103:4589-4598|
|Cedillo-Couvert, Esteban A; Ricardo, Ana C; Chen, Jinsong et al. (2018) Self-reported Medication Adherence and CKD Progression. Kidney Int Rep 3:645-651|
|Kamran, Neha; Chandran, Mayuri; Lowenstein, Pedro R et al. (2018) Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy. Clin Immunol 189:34-42|
|Rocco, Michael V; Sink, Kaycee M; Lovato, Laura C et al. (2018) Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis 71:352-361|
|Eisenberg, Marisa C; Campredon, Lora P; Brouwer, Andrew F et al. (2018) Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study. BMJ Open 8:e021618|
|Dickson, Robert P; Erb-Downward, John R; Falkowski, Nicole R et al. (2018) The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity. Am J Respir Crit Care Med 198:497-508|
|Kim, D-I; Liao, J; Emont, M P et al. (2018) An OLTAM system for analysis of brown/beige fat thermogenic activity. Int J Obes (Lond) 42:939-945|
Showing the most recent 10 out of 776 publications